Evidence map›Paper›PMID 33859779›Full record

ArticleOxidative medicine and cellular longevity2021

Increase in Blood-Brain Barrier (BBB) Permeability Is Regulated by MMP3 via the ERK Signaling Pathway.

Qin Zhang, Mei Zheng, Cristian E Betancourt, Lifeng Liu, Albert Sitikov, Nikola Sladojevic, Qiong Zhao, John H Zhang, James K Liao, Rongxue Wu

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Protective Effects of Luteolin onAntibiotics (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Infliximab modifies CD74-mediated lymphatic abnormalities and adipose tissue alterations in creeping fat of Crohn's disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Qin ZhangDepartment of Biological Sciences Division-Cardiology, University of Chicago, USA.
Mei ZhengDepartment of Biological Sciences Division-Cardiology, University of Chicago, USA.
Cristian E BetancourtDepartment of Biological Sciences Division-Cardiology, University of Chicago, USA.
Lifeng LiuDepartment of Biological Sciences Division-Cardiology, University of Chicago, USA.
Albert SitikovDepartment of Biological Sciences Division-Cardiology, University of Chicago, USA.
Nikola SladojevicDepartment of Biological Sciences Division-Cardiology, University of Chicago, USA.
Qiong ZhaoDivision of Cardiology, Department of Medicine, Inova Heart and Vascular Institute, USA.
John H ZhangCenter for Neuroscience Research, Loma Linda University, School of Medicine, USA.ORCID https://orcid.org/0000-0002-4319-4285
James K LiaoDepartment of Biological Sciences Division-Cardiology, University of Chicago, USA.
Rongxue WuDepartment of Biological Sciences Division-Cardiology, University of Chicago, USA.ORCID https://orcid.org/0000-0003-4857-4655
University of Chicago · USAlaska Heart and Vascular Institute · USLoma Linda University · US

Funding

Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Raghavendra G Mirmira · 2013 to 2026
$20.9M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
MULTIDISCIPLINARY CARDIAC SCIENCEST32HL007381 · NHLBI · UNIVERSITY OF CHICAGO · PI JEANNE M DECARA, Yoav Gilad · 1985 to 2026
$12.5M
ARNT: A novel regulator of cardiac vascular endothelial barrier function in heart failureR01HL140114 · NHLBI · UNIVERSITY OF CHICAGO · PI WU, RONGXUE · 2019 to 2023
$2.1M
Mechanisms Underlying Vascular AgingR01HL136962 · NHLBI · UNIVERSITY OF CHICAGO · PI LIAO, JAMES KUANG-JAN · 2018 to 2021
$1.8M
NCATS NIH HHS UL1 TR000430NHLBI NIH HHS R01 HL136962NHLBI NIH HHS R01 HL140114NHLBI NIH HHS T32 HL007381NIDDK NIH HHS P30 DK020595
6 · The paper itself

Abstract

backgroundThe blood-brain barrier (BBB) regulates the exchange of molecules between the brain and peripheral blood and is composed primarily of microvascular endothelial cells (BMVECs), which form the lining of cerebral blood vessels and are linked via tight junctions (TJs). The BBB is regulated by components of the extracellular matrix (ECM), and matrix metalloproteinase 3 (MMP3) remodels the ECM's basal lamina, which forms part of the BBB. Oxidative stress is implicated in activation of MMPs and impaired BBB. Thus, we investigated whether MMP3 modulates BBB permeability.

methodsExperiments included

resultsCompared to WT mice, measurements of isoflurane usage and anesthesia induction time were higher in MMP3-KO mice and lower in WT that had been treated with MMP3 (WT+MMP3), while anesthesia emergence times were shorter in MMP3-KO mice and longer in WT+MMP3 mice than in WT. Extravasation of systemically administered dyes was also lower in MMP3-KO mouse brains and higher in WT+MMP3 mouse brains, than in the brains of WT mice. The results from both TEER and Transwell assays indicated that MMP3 deficiency (or inhibition) increased, while MMP3 upregulation reduced barrier integrity in either BMVEC or the coculture. MMP3 deficiency also increased the abundance of TJs and VE-cadherin proteins in BMVECs, and the protein abundance declined when MMP3 activity was upregulated in BMVECs, but not when the cells were treated with an inhibitor of extracellular signal related-kinase (ERK).

conclusionMMP3 increases BBB permeability following the administration of isoflurane by upregulating the ERK signaling pathway, which subsequently reduces TJ and VE-cadherin proteins in BMVECs.

Indexed as

MAP Kinase Signaling SystemAnimalsBlood-Brain BarrierBrainEndothelial CellsHumansIsofluraneMatrix Metalloproteinase 3MiceMice, Inbred C57BLMice, KnockoutRecombinant ProteinsTight Junction ProteinsIsofluraneMatrix Metalloproteinase 3MMP3 protein, humanMmp3 protein, mouseRecombinant ProteinsTight Junction Proteins

Identifiers

PMID33859779
PMCPMC8026308
OpenAlexW3145573917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.